Variables | Â | HbA1c in Categories | Â | ||
---|---|---|---|---|---|
 | All patients | <5.5 % | 5.5 to <7 % | ≥7 % | P-value |
 | (N = 16,297) | (N = 3399) | (N = 9073) | (N = 3825) |  |
Patient characteristics | |||||
HbA1c (%), mean ± SD | 6.4 ± 1.6 | 5.0 ± 0.3 | 6.2 ± 0.4 | 8.0 ± 2.5 | <0.001 |
Demographics | Â | Â | Â | Â | Â |
 Age (years), mean ± SD | 64.7 ± 12.9 | 66.4 ± 12.6 | 65.8 ± 12.4 | 60.6 ± 13.4 | <0.001 |
 Male sex, N (%) | 8817 (54.1) | 1744 (51.3) | 4997 (55.1) | 2076 (54.3) | <0.001 |
 Race, N (%) |  |  |  |  | <0.001 |
  White | 10,439 (64.1) | 2158 (63.5) | 5887 (64.9) | 2394 (62.6) |  |
  Native American | 376 (2.4) | 56 (1.7) | 185 (2.0) | 135 (3.5) |  |
  Asian | 483 (3.0) | 108 (3.2) | 274 (3.0) | 101 (2.6) |  |
  Black | 4842 (29.7) | 1049 (30.9) | 2629 (29.0) | 1164 (30.4) |  |
  Pacific Islander | 110 (0.7) | 18 (0.5) | 69 (0.8) | 23 (0.6) |  |
  Other/Multiracial | 47 (0.3) | 10 (0.3) | 29 (0.3) | 8 (0.2) |  |
 Hispanic ethnicity, N (%) | 2847 (17.5) | 497 (14.6) | 1552 (17.1) | 798 (20.9) | <0.001 |
Reported comorbidities, N (%) | |||||
 Heart failure | 6369 (39.1) | 1251 (36.8) | 3666 (40.4) | 1452 (37.8) | <0.001 |
 Atherosclerotic heart disease | 3924 (24.1) | 735 (21.6) | 2316 (25.5) | 873 (22.8) | <0.001 |
 Cerebrovascular disease | 1747 (10.7) | 366 (10.8) | 983 (10.8) | 398 (10.4) | 0.77 |
 Peripheral vascular disease | 2669 (16.4) | 494 (14.5) | 1531 (16.9) | 644 (16.8) | 0.005 |
 Hypertension | 14,486 (89.0) | 3001 (88.3) | 8082 (89.1) | 3403 (89.0) | 0.45 |
 Amputation | 743 (4.6) | 137 (4.0) | 417 (4.6) | 189 (4.9) | 0.17 |
 Cancer | 936 (5.7) | 227 (6.7) | 574 (6.3) | 135 (3.5) | <0.001 |
Current tobacco use | 899 (5.5) | 186 (5.5) | 473 (5.2) | 240 (6.3) | 0.05 |
Socioeconomic variables | |||||
 Median rent ($), mean ± SD | 860.74 ± 272.49 | 867.67 ± 284.03 | 863.31 ± 271.87 | 848.47 ± 263.02 | 0.005 |
 Median household income ($), mean ± SD | 46,715 ± 16,970 | 46,569 ± 17,203 | 47,028 ± 17,107 | 46,102 ± 16,412 | 0.02 |
 % below poverty, mean ± SD | 17.9 ± 10.1 | 17.8 ± 10.0 | 17.6 ± 10.0 | 18.7 ± 10.3 | <0.001 |
 % unemployed, mean ± SD | 6.3 ± 2.6 | 6.3 ± 2.7 | 6.2 ± 2.6 | 6.4 ± 2.5 | 0.007 |
 % < high school education, mean ± SD | 17.4 ± 10.8 | 16.9 ± 10.3 | 17.2 ± 10.7 | 18.4 ± 11.3 | <0.001 |
Antidiabetic medication use, N (%) | |||||
 Insulin | 10,676 (65.5) | 1795 (52.8) | 5886 (64.9) | 2995 (78.3) | <0.001 |
 Oral antidiabetic medications | 4404 (27.0) | 1141 (33.6) | 2499 (27.5) | 764 (20.0) | <0.001 |
 Both insulin and oral antidiabetic medications | 427 (4.0) | 71 (4.0) | 230 (3.9) | 126 (4.2) | <0.001 |
 No medications | 1528 (9.4) | 519 (15.3) | 853 (9.4) | 156 (4.1) | <0.001 |
Laboratory measurements | |||||
 Body mass index (kg/m2), mean ± SD | 30.3 ± 7.8 | 29.6 ± 7.6 | 30.4 ± 7.8 | 30.7 ± 8.0 | <0.001 |
 Platelet count (×103/μL), median (25th–75th percentile) | 236.0 (186.0–296.0) | 226.0 (174.0–285.0) | 235.0 (186.0–294.0) | 245.0 (198.0–311.0) | <0.001 |
 White blood cell count (x1000/mm3), mean ± SD | 7.6 ± 2.6 | 7.3 ± 2.6 | 7.6 ± 2.6 | 7.9 ± 2.7 | <0.001 |
 Ferritin (ng/mL), mean ± SD | 365.5 ± 342.8 | 370.0 ± 347.1 | 373.4 ± 343.9 | 343.1 ± 335.4 | <0.001 |
 Total cholesterol (mg/dL), median (25th–75th percentile) | 143.0 (118.0–173.0) | 138.0 (115.0–166.0) | 141.0 (116.0–171.0) | 153.0 (126.0–185.0) | <0.001 |
 LDL (mg/dL), median (25th–75th percentile) | 72.0 (52.0–96.0) | 70.0 (51.0–93.0) | 71.0 (51.0–95.0) | 77.0 (56.0–103.0) | <0.001 |
 HDL (mg/dL), median (25th–75th percentile) | 38.0 (31.0–48.0) | 39.0 (31.0–49.0) | 38.0 (30.0–47.0) | 39.0 (32.0–50.0) | <0.001 |
 Triglycerides (mg/dL), median (25th–75th percentile) | 135.0 (96.0–191.0) | 123.0 (89.0–172.0) | 135.0 (96.0–190.0) | 148.0 (104.0–214.0) | <0.001 |
 Systolic blood pressure (mmHg), median (25th–75th percentile) | 150.0 (132.0–169.0) | 147.0 (129.0–167.0) | 149.0 (131.0–168.0) | 153.0 (135.0–173.0) | <0.001 |
 Diastolic blood pressure (mm Hg), median (25th–75th percentile) | 75.0 (65.0–87.0) | 75.0 (64.0–85.0) | 75.0 (64.0–86.0) | 78.0 (67.0–90.0) | <0.001 |
 Albumin (g/dL), mean ± SD | 3.6 ± 0.5 | 3.5 ± 0.5 | 3.6 ± 0.5 | 3.5 ± 0.4 | <0.001 |
 Normalized protein catabolic rate (g/kg/d), mean ± SD | 0.91 ± 0.32 | 0.88 ± 0.28 | 0.92 ± 0.32 | 0.93 ± 0.32 | <0.001 |
 Estimated GFRb (mL/min/1.73 m2), mean ± SD | 11.4 ± 4.8 | 10.9 ± 4.9 | 11.4 ± 4.7 | 11.7 ± 4.7 | <0.001 |
 Hemoglobin (g/dL), mean ± SD | 12.1 ± 1.5 | 12.0 ± 1.6 | 12.1 ± 1.5 | 12.3 ± 1.5 | <0.001 |